129 related articles for article (PubMed ID: 29495204)
1. [Association between DRD2 gene polymorphisms and the dosage used on methadone maintenance treatment program].
Duan LX; Li XL; Hu PW; Luo R; Luo X; Chen YY
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):194-198. PubMed ID: 29495204
[No Abstract] [Full Text] [Related]
2. Contribution of BDNF and DRD2 genetic polymorphisms to continued opioid use in patients receiving methadone treatment for opioid use disorder: an observational study.
Bawor M; Dennis BB; Tan C; Pare G; Varenbut M; Daiter J; Plater C; Worster A; Marsh DC; Steiner M; Anglin R; Desai D; Thabane L; Samaan Z
Addict Sci Clin Pract; 2015 Oct; 10():19. PubMed ID: 26437921
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution.
Doehring A; Hentig Nv; Graff J; Salamat S; Schmidt M; Geisslinger G; Harder S; Lötsch J
Pharmacogenet Genomics; 2009 Jun; 19(6):407-14. PubMed ID: 19373123
[TBL] [Abstract][Full Text] [Related]
4. Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes.
Fonseca F; Gratacòs M; Escaramís G; De Cid R; Martín-Santos R; Fernández-Espejo E; Estivill X; Torrens M
Mol Diagn Ther; 2010 Jun; 14(3):171-8. PubMed ID: 20560679
[TBL] [Abstract][Full Text] [Related]
5. Association of
Duan L; Li X; Yan J; Chen Y; Luo R; Zhang Q; Feng X; Li X
Genet Test Mol Biomarkers; 2020 Jun; 24(6):364-369. PubMed ID: 32407152
[No Abstract] [Full Text] [Related]
6. Patient perception of methadone dose adequacy in methadone maintenance treatment: The role of perceived participation in dosage decisions.
Trujols J; González-Saiz F; Manresa MJ; Alcaraz S; Batlle F; Duran-Sindreu S; Pérez de Los Cobos J
Patient Educ Couns; 2017 May; 100(5):981-986. PubMed ID: 27988071
[TBL] [Abstract][Full Text] [Related]
7. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
[TBL] [Abstract][Full Text] [Related]
8. Impact of SNP-SNP interaction among ABCB1, ARRB2, DRD1 and OPRD1 on methadone dosage requirement in Han Chinese patients.
Luo R; Li X; Qin S; Luo Z; Luo X; Hu P; Liu Z; Feng X; Li X
Pharmacogenomics; 2017 Dec; 18(18):1659-1670. PubMed ID: 29173032
[TBL] [Abstract][Full Text] [Related]
9. Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment.
Crettol S; Besson J; Croquette-Krokar M; Hämmig R; Gothuey I; Monnat M; Déglon JJ; Preisig M; Eap CB
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1722-7. PubMed ID: 18687376
[TBL] [Abstract][Full Text] [Related]
10. ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse.
Spellicy CJ; Kosten TR; Hamon SC; Harding MJ; Nielsen DA
Pharmacogenet Genomics; 2013 Jul; 23(7):333-40. PubMed ID: 23635803
[TBL] [Abstract][Full Text] [Related]
11. Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients.
Hung CC; Chiou MH; Huang BH; Hsieh YW; Hsieh TJ; Huang CL; Lane HY
Pharmacogenomics; 2011 Nov; 12(11):1525-33. PubMed ID: 21902500
[TBL] [Abstract][Full Text] [Related]
12. ABCB1 Polymorphisms and Cold Pressor Pain Responses: Opioid-Dependent Patients on Methadone Maintenance Therapy.
Zahari Z; Lee CS; Ibrahim MA; Musa N; Mohd Yasin MA; Lee YY; Tan SC; Mohamad N; Ismail R
Nurs Res; 2017; 66(2):134-144. PubMed ID: 28252574
[TBL] [Abstract][Full Text] [Related]
13. Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity.
Mouly S; Bloch V; Peoc'h K; Houze P; Labat L; Ksouda K; Simoneau G; Declèves X; Bergmann JF; Scherrmann JM; Laplanche JL; Lepine JP; Vorspan F
Br J Clin Pharmacol; 2015 Jun; 79(6):967-77. PubMed ID: 25556837
[TBL] [Abstract][Full Text] [Related]
14. Association of OPRK1 gene polymorphisms with opioid dependence in addicted men undergoing methadone treatment in an Iranian population.
Albonaim A; Fazel H; Sharafshah A; Omarmeli V; Rezaei S; Ajamian F; Keshavarz P
J Addict Dis; 2017; 36(4):227-235. PubMed ID: 28786760
[TBL] [Abstract][Full Text] [Related]
15. Association between the DRD2 A1 allele and response to methadone and buprenorphine maintenance treatments.
Barratt DT; Coller JK; Somogyi AA
Am J Med Genet B Neuropsychiatr Genet; 2006 Jun; 141B(4):323-31. PubMed ID: 16583408
[TBL] [Abstract][Full Text] [Related]
16. APBB2 is associated with amphetamine use and plasma beta-amyloids in patients receiving methadone maintenance treatment.
Liu CC; Fang CP; Liu TH; Kuo HW; Liu SC; Wang SC; Chen ACH; Liu YL
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():92-98. PubMed ID: 29330135
[TBL] [Abstract][Full Text] [Related]
17. Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction.
Levran O; Peles E; Randesi M; Shu X; Ott J; Shen PH; Adelson M; Kreek MJ
Pharmacogenomics; 2013 May; 14(7):755-68. PubMed ID: 23651024
[TBL] [Abstract][Full Text] [Related]
18. The D(2) dopamine receptor A(1) allele and opioid dependence: association with heroin use and response to methadone treatment.
Lawford BR; Young RM; Noble EP; Sargent J; Rowell J; Shadforth S; Zhang X; Ritchie T
Am J Med Genet; 2000 Oct; 96(5):592-8. PubMed ID: 11054765
[TBL] [Abstract][Full Text] [Related]
19. The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review.
Oueslati B; Moula O; Ghachem R
Pharmacogenomics; 2018 Jun; 19(8):741-747. PubMed ID: 29785888
[TBL] [Abstract][Full Text] [Related]
20. Association between polymorphisms of DRD2 and DRD4 and opioid dependence: evidence from the current studies.
Chen D; Liu F; Shang Q; Song X; Miao X; Wang Z
Am J Med Genet B Neuropsychiatr Genet; 2011 Sep; 156B(6):661-70. PubMed ID: 21714067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
